Helixmith Co., Ltd.

This study aimed to test whether an experimental drug called TADIOS could help people hospitalized with mild to moderate COVID-19 recover faster. It was designed for adults aged 18 to 65 who had a confirmed first-time COVID-19 infection. However, the trial was withdrawn before en…

This study aimed to test a new gene therapy called VM202RY for people who had a recent heart attack. The treatment was injected directly into the heart to see if it could improve heart function. The study was withdrawn before any participants were enrolled, so no results are avai…

This study was designed to test the safety of injecting a gene therapy called VM202 directly into the heart muscle of people with severe, long-term chest pain due to blocked arteries. The treatment aimed to help grow new blood vessels to improve blood flow. However, the study was…

This study aimed to test a gene therapy for X-linked chronic granulomatous disease, a rare immune disorder that makes patients prone to severe infections. The plan was to take the patient's own blood stem cells, add a corrected gene, and return them to the body. However, the tria…

This study was designed to see if the herbal tablet PG201 could reduce pain and improve function in people with knee osteoarthritis. It planned to enroll adults aged 40 to 75 and compare different doses against a placebo over 8 weeks. However, the study was withdrawn before any p…